Managed Care Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adams Respiratory Therapeutics, Inc.
Pharma firm sets pricing for public offering
August 16th, 2005
Adams Respiratory Therapeutics, Inc., (ARXT) announced the pricing of its initial public offering of 7,950,000 shares of its common stock at a price of $17.00 per share. Of the 7,950,000 shares being sold in the offering, 5,697,000 shares are being sold by Adams and 2,253,000 are being sold by certain selling stockholders. In addition, Adams has granted to the underwriters a 30-day over-allotment option to purchase up to an additional 1,192,000 shares. The Adams common stock is expected to begin trading on the Nasdaq National Market on July 21, 2005, under the symbol "ARXT." The proceeds to Adams from the offering are expected to be approximately...
Source: Managed Care Business Week (2005-08-16)
|
